Loading…
← CockpitCompetitor Analysis › 4203.T Sumitomo Bakelite Co., Ltd.Open in the cockpit ↗

Sumitomo Bakelite Co., Ltd.4203.TCompetitor analysis, valuation and peers

Japan · JPY·Health Care›Medical Specialties

Japanese maker of phenolic and other specialty resins, also producing medical devices and semiconductor packaging materials.

≈ A diversified specialty-materials maker spanning plastics, medical devices and semiconductMomentum weak 35
Mkt cap
$3.50B
US dollars, full cap
Free float
80%
of shares outstanding
$/day
$55.1M
20-day average traded
Fwd P/E
15.9×
forward earnings
ROIC−WACC
+1.1 pp
WACC 11.7%
Hurdle
-0 pp
Req g minus delivered
Next earnings
82 days
8 Feb 2027
Close · JPY¥7,003
1D+1.8%
1W-7.5%
1M-19.0%
3M-10.2%
6M+6.6%
YTD+35.6%
1Y+37.9%
ATR %6.5%
52w lowhigh26.1% off high

What Sumitomo Bakelite does

Japanese maker of phenolic and other specialty resins, also producing medical devices and semiconductor packaging materials.

Sells resins and moulding compounds as ingredients that customers qualify for their own processes, so volumes follow customers' production in cars, electronics and chip packaging. Moulding compounds, which encase chips for protection, and phenolic resins carry the business; medical devices such as syringes and catheters are a separate, smaller line.

In one line: A diversified specialty-materials maker spanning plastics, medical devices and semiconduct.

Products and services

  • Phenolic/specialty resins
  • Semiconductor packaging materials
  • Medical devices (syringes, catheters)

Customers

  • Automotive/electronics manufacturers
  • Semiconductor packagers
  • Hospitals

Where it sits in the supply chain

  • Materials/Health care
  • Specialty resins and medical devices
  • Phenolic resins, semiconductor…

What could go right

  • Semiconductor packaging growth
  • Medical device demand

What could go wrong

  • Petrochemical cost swings
  • Auto production cyclicality

Moat: narrow (process know-how, customer qualification). Resin formulations qualified into automotive and semiconductor packaging processes create switching costs.

Headquarters: Tokyo, Japan · Founded: 1932 · Employees: 7,524

Named competitors

Sumitomo Bakelite at a glance

Size Sumitomo Bakelite (4203.T) is a Japan Health Care company (Medical Specialties) with a market value of $3.50B, the 329th largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥7,003 on 18 Nov 2026.

Performance Over six months the shares gained 6.6%, against -0.4% for the median peer and -1.4% for the Japan market (cap-weighted) — 10th highest of 21 in its peer set.

Growth Revenue grew 15.3% over the last twelve months (peer median +5.7%); the operating margin is 12.8% (peer median 11.6%).

Valuation It trades at 15.9× forward earnings against a peer median of 24.4× (2nd cheapest of 19).

Price implies For today's price to make sense, revenue must grow about 9% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is -0 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 1.1 points above its cost of capital (11.7% WACC).

Next results Next results expected around 8 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012014021 May 202621 Aug 202618 Nov 20264203.T 108Peer median 101
Six months, rebased to 100: Sumitomo Bakelite against the median of its 20 peers (local-currency closes).

Sumitomo Bakelite financials

Reported figures in JPY; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue¥355B¥320B¥305B¥287B¥285B
Revenue growth—+5%+6%+1%—
Gross profit¥116B¥96.1B¥89.4B¥81.6B¥77.3B
EBITDA¥60.5B¥48.7B¥44.8B¥41.1B¥39.3B
Net income¥34.3B¥28.0B¥19.3B¥21.8B¥20.3B
Free cash flow¥21.9B¥19.6B¥28.1B¥18.3B¥8.65B
Capital expenditure¥19.7B¥17.7B¥15.6B¥21.9B¥15.0B
Total debt¥16.9B¥27.4B¥30.7B¥48.5B¥43.2B

Quarterly statements and history in the cockpit →

Sumitomo Bakelite competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-25%0%+25%+50%+75%-20%0%+20%AMBU-BAXGNTECNPLSE603014603658TMDX6883011SXP603301NVST300003IRTC002432AFXCDNAFIE688114002223STVN4203.T6-month return →1-month return →
Up and to the right = strong over both horizons. Sumitomo Bakelite is the large dot.

Fundamentals: revenue growth against valuation

-25%0%+25%+50%25×50×75×100×AMBU-BAXGNTECN603014603658TMDX688301603301NVST300003IRTC002432CDNASTVN4203.TRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Sumitomo Bakelite is the large dot.

Capital: growth delivered against growth the price implies

0%+25%+50%+75%0%50%AMBU-BAXGNTECN603014603658TMDX1SXP603301300003IRTC002432FIE6881144203.TGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Sumitomo Bakelite is the large dot.

Sumitomo Bakelite competitors and peer comparison

Head to head with its named competitors (4203.T vs 4118.T vs 4543.T vs 4004.T)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Sumitomo Bakelite 4203.T$3.50B+7%+15%13%15.9×8.6%
Kaneka 4118.T$2.35B+17%+6%5%12.0×3.3%
Terumo 4543.T$24.0B+32%+15%17%27.8×8.8%
Resonac 4004.T$13.8B-29%-9%15%21.8×20.0%
Nitto Denko 6988.T$13.9B+18%+7%18%16.1×3.9%
Asahi Yukizai 4216.T$634M-7%+1%11%16.5×-1.4%
NIPRO 8086.T$1.68B-11%+5%5%15.8×n/a

How Sumitomo Bakelite compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Sumitomo Bakelite against its 20 peers (data as of 18 Nov 2026)
Measure4203.TPeer medianRank in peer set
1-month return-19.0%+3.5%3rd lowest of 21
6-month return+6.6%-0.4%10th highest of 21
Distance from 52-week high-26.1%-25.8%11th highest of 21
Revenue growth (TTM)+15.3%+5.7%7th highest of 21
Operating margin12.8%11.6%8th highest of 20
Forward P/E15.9×24.4×2nd cheapest of 19
Growth the price implies (Req g, 7 yrs)8.6%12.5%7th least demanding of 18
Growth delivered (Del g)+8.9%+8.1%9th highest of 18
Hurdle (Req g minus delivered)-0.3 pp+1.5 pp6th least demanding of 18
ROIC minus cost of capital+1.1 pp-1.1 pp6th highest of 19
EV / EBITDA7.2×13.8×cheapest of 10
Net debt / EBITDA-2.0×1.0×2nd least indebted of 11

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Sumitomo Bakelite 4203.TJapan$3.50B+7%+15%13%15.9×8.6%+8.9%
Ambu A/S AMBU-B.CODenmark$3.47B+31%+7%13%28.8×10.0%+10.0%
Axogen AXGNUnited States$3.40B+33%+24%-5%87.3×52.6%+14.9%
Tecan TECN.SWSwitzerland$3.60B+59%-4%1%35.5×45.4%+3.8%
Pulse Biosciences PLSEUnited States$3.37B+76%+1,637%-5,821%n/an/an/a
Shandong Weigao Blood Purification Products 603014.SSChina$3.63B-1%+4%n/a20.4×-1.2%+8.1%
Autobio Diagnostics 603658.SSChina$3.36B+16%+3%25%20.3×-0.4%+7.2%
TransMedics TMDXUnited States$3.35B+42%+28%12%43.4×38.4%+88.2%
iRay Technology 688301.SSChina$3.31B-30%+58%24%25.7×n/an/a
SCHOTT Pharma AG & Co. KGaA 1SXP.DEGermany$3.73B+32%+4%15%23.0×12.7%+11.0%
Zhende Medical 603301.SSChina$3.26B-10%+8%7%42.5×22.9%-16.1%
Envista NVSTUnited States$3.81B0%+10%12%14.7×4.8%+7.1%
Lepu Medical Technology (Beijing) 300003.SZChina$3.20B-13%-1%13%24.4×8.7%-4.2%
iRhythm IRTCUnited States$3.19B-19%+22%5%99.8×46.9%+23.0%
Andon Health 002432.SZChina$3.86B-24%-30%-26%16.1×-6.6%-7.4%
Carl Zeiss Meditec AFX.DEGermany$3.17B+22%0%8%24.4×12.5%+10.8%
CareDx CDNAUnited States$3.91B+252%+39%1%50.6×n/an/a
Fielmann FIE.DEGermany$3.92B-3%+3%14%17.1×-5.5%+11.3%
MGI Tech 688114.SSChina$3.06B-4%+2%-7%n/a43.7%-0.1%
Jiangsu Yuyue Medical Equipment & Supply 002223.SZChina$4.18B-3%-1%13%20.0×4.9%+3.4%
Stevanato STVNUnited States$4.19B-13%+12%18%22.5×13.1%+12.1%

Questions

Who are Sumitomo Bakelite's main competitors?
Named competitors: Kaneka (4118.T), Terumo (4543.T), Resonac (4004.T), Nitto Denko (6988.T), Asahi Yukizai (4216.T), Nipro (8086.T). The cockpit's measured peer set (industry) also includes Ambu A/S (AMBU-B.CO), Axogen (AXGN), Tecan (TECN.SW), Pulse Biosciences (PLSE), Shandong Weigao Blood Purification Products (603014.SS), Autobio Diagnostics (603658.SS).
Is Sumitomo Bakelite expensive compared with its peers?
On forward p/e it trades at 15.9× against a peer median of 24.4×, 2nd cheapest of 19 in its peer set. For today's price to make sense, revenue must grow about 9% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is -0 pp: the price already allows for a slowdown.
How has Sumitomo Bakelite stock performed?
Over six months to 18 Nov 2026 the shares returned +6.6% against -0.4% for the median peer; over one year +37.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.